Ph.D. Student (2011-2017)
Current position: Postdoctoral Fellow at the University of Kansas School of Pharmacy, Lawrence, Kansas
Honors and Awards
Guo Y, Pope C, Cheng X, Zhou H, and Klaassen CD. Dose-response of berberine on hepatic cytochromes P450 mRNA expression and activities in mice. J Ethnopharmacol. 2011, 138(1):111-8.
Kazmi F, Hensley T, Pope C, Funk RS, Loewen GJ, Buckley D, and Parkinson A. Lysosomal sequestration (trapping) of lipophilic amine (cationic amphiphilic) drugs in immortalized human hepatocytes (Fa2N-4 cells). Drug Metabolism and Disposition, 2013, 41(4):897-905.
Tien YC, Liu K, Pope C, Wang P, Ma X, and Zhong XB. Dose of phenobarbital and age of treatment at early life are two key factors for the persistent induction of cytochrome P450 enzymes in adult mouse liver. Drug Metabolism and Disposition, 2015, 43(12):1938-1945. PMID:26400395. PMCID:PMC4658495.
Tien YC, Piekos SC, Pope C, and Zhong XB. Phenobarbital treatment at a neonatal age results in decreased efficacy of omeprazole in adult mice. Drug Metabolism and Disposition, 2017, 45(3):330-335. PMID:28062542. PMCID:PMC5325062.
Piekos S, Pope C, Ferrara A, and Zhong XB. Impact of drug treatment at neonatal ages on variability of drug metabolism and drug-drug interactions in adult life. Current Pharmacology Reports, 2017, 3(1):1-9. PMID:28344923. PMCID:PMC5362116.
Pope C, Mishra S, Russell J, Zhou Q, and Zhong XB. Targeting H19, an imprinted long non-coding RNA, in hepatic functions and liver diseases. Diseases, 5(1):11. doi:10.3390/diseases5010011.
Song Y, Liu C, Zhang L, Ananthanarayanan A, Beaudoin, M, Pope C, Zhong XB, Li L, and Wang L. H19 promotes cholestatic liver fibrosis by preventing ZEB1-mediated inhibition of EpCAM. Hepatology, 2017, accepted.
|Mailing Address||Department of Pharmaceutical Sciences, School of Pharmacy, University of Connecticut, 69 North Eagleville Road, Storrs, CT 06269|